We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Drug Combo Reverses Osteoarthritis in Rats

News   Jan 22, 2020 | Original story from Salk Institute

 
Drug Combo Reverses Osteoarthritis in Rats

The top image shows a knee joint in a healthy rat. (White indicates cartilage.) The second image from top shows a joint with grade 2 untreated osteoarthritis. The third image shows a joint with osteoarthritis that has worsened from grade 2 to grade 4 after six weeks of placebo therapy. The bottom image shows a joint with osteoarthritis that improved from grade 2 to grade 1 (mild) after six weeks of combination therapy with alphaKlotho and sTGFbR2. Credit: Salk Institute

 
 
 

RELATED ARTICLES

Atomic Structures of Flu, Measles, Mumps and RSV Mapped

News

The 3D atomic structure of a key complex in paramyxoviruses, a family of viruses that includes mumps, human parainfluenza and respiratory syncytial virus (RSV), have been determined. This information could help design and development of antiviral drugs for these viruses as well as for coronavirus, which functions similarly to paramyxoviruses.

READ MORE

Social Media’s Power in Spreading Vaccine Misinformation

News

People who rely on social media for information were more likely to be misinformed about vaccines than those who rely on traditional media, according to a study of vaccine knowledge and media use.

READ MORE

Drug Combo for Childhood Brain Tumors Shows Promise in Lab Models

News

Combining the experimental cancer drug TAK228 (sapanisertib) with an existing anti-cancer drug called trametinib may be more effective than either drug alone in decreasing the growth of pediatric low-grade gliomas, according to findings using animal and cell models.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE